Lv1
20 积分 2026-04-04 加入
Epigenetic therapy in immune-oncology
4个月前
已完结
Tertiary Lymphoid Structures and Immunotherapy: Challenges and Opportunities
5个月前
已完结
cGAS‐STING pathway agonists are promising vaccine adjuvants
5个月前
已完结
Tertiary Lymphoid Structures and Immunotherapy: Challenges and Opportunities
5个月前
已完结
Pancreatic ductal adenocarcinoma: tumour regression grading following neoadjuvant FOLFIRINOX and radiation
5个月前
已完结
A Phase II Study of Neoadjuvant GVAX and Cyclophosphamide Combined with Nivolumab and SBRT Followed by Surgery in Borderline Resectable Pancreatic Adenocarcinoma
5个月前
已完结
Tertiary lymphoid structures in anticancer immunity
5个月前
已完结
Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas
5个月前
已完结
Maturation of Tertiary Lymphoid Structures
5个月前
已完结
Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection
5个月前
已关闭
皖公网安备34019202002308
